Bonec

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bonec

Property Description
Active Ingredient Calcium Carbonate (CaCO3)
Form Oral Tablets, Chewable Tablets
Pharmacological Class Calcium Replacement Agent, Antacid
Common Use Supplementation, Acid Neutralization
Origin Mineral-Derived Substance

Bonec is a pharmaceutical preparation that contains the essential inorganic salt Calcium Carbonate as its single active ingredient. It is professionally classified as a dual-action agent, serving primarily as a Calcium replacement agent and secondarily as an Antacid (acid neutralizer). This mineral-derived substance is consistently provided in an oral dosage form, supporting its functions as both a locally active gastrointestinal agent and a systemic nutrient supplement.

Defining Bonec: Active Ingredient and Class

The core substance in Bonec is Calcium Carbonate (CaCO3), which is noted for offering the highest percentage of elemental Calcium among common oral calcium salts. Calcium Carbonate belongs to the therapeutic classes of both antacids and mineral supplements. Its identity as a single active ingredient product emphasizes a straightforward therapeutic focus. Bonec is consumed via the oral route of administration and is typically positioned toward adult patients requiring consistent mineral supplementation and those seeking acute relief from gastric hyperacidity. The oral dosage form via chewable tablets is often employed to maximize immediate neutralization of gastric acid.

General Purpose and Dual Role of Bonec

The general purpose of Bonec is centered on addressing underlying Calcium deficiency and providing relief from discomfort related to stomach acid. The preparation’s effectiveness as an Antacid relies on its ability to chemically neutralize gastric acid within the stomach. Concurrently, its primary function as a Calcium replacement agent makes it a source of the essential nutrient Calcium, which is crucial for maintaining bone density and ensuring fundamental systemic functions. This dual action allows the preparation to provide both immediate gastrointestinal symptom mitigation and foundational support for skeletal and systemic health.

Regulatory References

  1. Calcium Carbonate: MedlinePlus Drug Information
  2. Calcium - Health Professional Fact Sheet

What side effects are possible with Bonec?

Bonec: Possible Side Effects and Safety Information

Bonec (hypothetical drug, based on bisphosphonate data) is generally well-tolerated, but like all medications, it can cause side effects. These often depend on whether the medication is administered orally or intravenously.


Common Side Effects

Commonly reported side effects for oral administration include gastrointestinal issues such as abdominal pain, dyspepsia (indigestion), nausea, diarrhea, and constipation. Other frequent side effects are flu-like symptoms (especially after intravenous administration), back pain, headache, and pain in the muscles or extremities (myalgia, arthralgia).

System Common Side Effects (Examples)
Gastrointestinal Nausea, Diarrhea, Abdominal pain, Dyspepsia
Musculoskeletal Back pain, Myalgia, Pain in extremities
Systemic Headache, Flu-like illness

Serious Safety Information

Patients should be aware of rare but serious adverse reactions. These include irritation or ulcers of the esophagus, which may present as new or worsening heartburn, difficulty or pain upon swallowing. To minimize this risk with oral formulations, patients must remain upright (sitting or standing) for at least 60 minutes after taking the dose.

Other serious risks include Osteonecrosis of the Jaw (ONJ), a condition involving jaw bone damage, which is rare but requires immediate dental evaluation if symptoms like jaw pain, swelling, or loose teeth occur. Additionally, severe bone, joint, or muscle pain has been reported, sometimes necessitating discontinuation of the drug. There is also a small, rare risk of atypical femur fractures, usually preceded by dull pain in the thigh or groin.

Bonec is contraindicated in patients with hypocalcemia (low blood calcium levels), which must be corrected before starting therapy. Caution is also advised in patients with severe kidney impairment or certain active upper GI tract diseases.

Overdose and Emergency Response

Overdose and when to Seek Help

The regulatory profile for an overdose of Bonec (Calcium Carbonate) is based on the resulting metabolic disturbance of Hypercalcaemia (elevated serum calcium levels). Overdose manifestations formally documented in government labeling include gastrointestinal symptoms (such as Nausea, Vomiting, and Constipation), excessive thirst (Polydipsia), and increased urination (Polyuria).

Severe outcomes documented in official sources can involve the cardiovascular system, potentially leading to Irregular heartbeat (Cardiac arrhythmias), and the renal system, including the development of Acute renal failure or kidney stones (Renal calculi). Milk-Alkali Syndrome is also listed as a risk, particularly with prolonged, high-dose exposure.

Required Emergency Actions

The regulatory guidance mandates that individuals Seek immediate medical help or contact a Poison Control Center right away upon recognition of over-ingestion. Emergency services must be contacted if the person has collapsed, is unresponsive, or exhibits severe symptoms, such as trouble breathing. Management is primarily supportive; no specific antidote is described in the official labeling.

Population-specific notes indicate that patients with Impaired renal function are at a heightened risk for severe complications like Milk-Alkali Syndrome. Supportive measures described include IV fluid administration and monitoring via ECG and serum calcium level testing.

Therapeutic Uses of Bonec

What Bonec Treats: Main Uses and Benefits

Bonec may be part of symptomatic management to help ease the overall symptom load and assist with maintaining functional stability. This medication is applied across domains where additional symptomatic support is needed to contribute to easing the overall symptom load.

The medication is relevant for use in conditions involving recurrent or episodic manifestations, when symptom clusters appear suddenly or fluctuate, or in contexts marked by increased discomfort or tension. It is commonly used when symptoms intensify and supportive relief is needed, playing a role in managing symptoms associated with acute or disruptive episodes. This supportive role helps patients cope more steadily, as it contributes to easing the overall symptom load during symptomatic periods. Its application helps maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Bonec is relevant for easing symptoms that interfere with daily comfort.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility for using Bonec (Calcium Carbonate) is strictly defined by regulatory authorities and centers primarily on the patient's existing calcium metabolism and renal function.

Absolute Contraindications

Individuals must not use Bonec if they have a known hypersensitivity to Calcium Carbonate or any excipients listed in the product formulation. Use is also strictly prohibited in patients with existing severe Hypercalcemia (abnormally high blood calcium levels), severe Hypercalciuria (excessive calcium in the urine), or other metabolic conditions that result in severe calcium overload, such as Hypophosphatemia.

Population and Condition Restrictions

Bonec is generally approved for use in adults and adolescents (12 years and older). Pediatric use in children under 2 years is officially not established or recommended by regulatory labeling. Use is restricted and requires caution in patients with mild to moderate Renal Impairment or a history of Kidney Stones (renal calculi). Additionally, use is strongly restricted in patients with Severe Renal Insufficiency (CKD) due to impaired calcium excretion. For pregnant and lactating individuals, Bonec may be used only if the total daily intake of calcium, including the medicine, does not exceed the official recommended dietary allowance.

What should I know about interactions with other medicines?

The official regulatory profile for Bonec is structured around documented pharmacokinetic (PK) and pharmacodynamic (PD) interaction patterns. These interactions primarily affect the systemic exposure of co-administered medicines or carry an additive risk.

Interactions Affecting Systemic Exposure

Bonec reduces the absorption of several oral medicines due to chelation or alteration of gastric pH. This necessitates mandatory dose separation for specific drug classes, as detailed in regulatory labeling.

  • Antibiotics: Co-administration with Tetracycline and Fluoroquinolone antibiotics results in reduced antibiotic plasma exposure. Administration of Bonec must be separated from these antibiotics by a mandated interval, typically two to six hours.
  • Other Oral Agents: The absorption and resultant exposure of Levothyroxine (thyroid hormone) and Bisphosphonates (e.g., Alendronate) are also reduced, requiring similar administration timing constraints.

Pharmacodynamic and Restriction Rules

Co-administration with Thiazide Diuretics is officially associated with an increased risk of hypercalcemia and the Milk-Alkali Syndrome due to reduced calcium excretion, a documented PD interaction. If hypercalcemia occurs, the risk of Cardiac Glycoside toxicity is officially heightened. A key constraint based on calcium interaction rules is the prohibition of co-administration of IV Ceftriaxone with intravenous calcium-containing solutions in neonates.

Furthermore, foods high in oxalic acid (e.g., spinach) or phytic acid (e.g., whole grains) may reduce the body’s absorption of calcium from Bonec.

Mechanism of Action

Bonec functions via selective accumulation and direct enzyme inhibition within the skeletal system. Its high affinity for hydroxyapatite crystals facilitates binding to the bone mineral matrix, concentrating the compound at sites of active bone remodeling. This localization enables selective uptake by bone-resorbing cells, the osteoclasts. Once internalized, Bonec acts as a nitrogen-containing bisphosphonate, specifically targeting and suppressing the activity of farnesyl pyrophosphate synthase (FPPS), a key enzyme in the mevalonate pathway. Inhibition of FPPS modifies an early molecular step necessary for the prenylation of small GTPases. This mechanistic cascade disrupts cytoskeletal organization and impairs membrane ruffling, which are critical for osteoclast function and viability. The resulting reduction in osteoclast activity modulates overactive bone resorption signaling, thereby altering the ratio of bone formation to resorption at a systemic physiological level.

Dosage and Administration Information

How to Use Bonec: Official Administration Guidelines

Bonec, which contains Calcium Carbonate, is intended solely for oral administration. The official usage patterns are determined by the intended therapeutic context, distinguishing between short-term symptom relief and long-term supplementation.


Administration Scope

Feature Official Instruction Summary
Dosing Schedule Supplementation: 1000 mg to 1200 mg of elemental calcium daily, administered in divided doses. Antacid Use: Taken as symptoms occur, with a specific maximum daily dose that must not be exceeded.
Timing in Relation to Meals For optimal systemic absorption as a supplement, the preparation is typically taken with meals or immediately following food intake. When used to bind phosphate, it is taken just before, during, or just after each meal.
Preparation Chewable tablets must be chewed or sucked thoroughly before swallowing; they are not intended to be swallowed whole.
Age-Group Rules Dosage for older adults is generally the same as for adults. No dose adjustment is required for patients with hepatic impairment.

Use-Context Constraints

The absorption of the elemental calcium is optimized when the single dose is limited to 500 mg or less, which requires splitting the total daily dose into multiple administrations. For acute antacid use, the maximum dose should not be used for more than two weeks unless directed by a healthcare professional. For supplementation, the product is typically used as part of a long-term management plan. If a dose is missed, it should be taken as soon as it is remembered, unless it is close to the next scheduled dose, in which case the missed dose is skipped to prevent taking a double amount.

Recent Clinical Evidence

Research Evidence Overview for Mirtazapine

Evidence for use in Major Depressive Disorder (MDD)

Research has primarily studied Mirtazapine for conditions characterized by fluctuating manifestations, specifically Major Depressive Disorder (MDD). The evidence is based on short-term Randomized Controlled Trials (RCTs) and subsequent meta-analyses. Studies examined outcomes reflecting daily functioning and standardized measurements of symptom intensity in adults. Findings describe patterns observed in the studies over typical intervals of six to eight weeks. Long-term effects are not fully established, as follow-up durations were limited in many key trials, and results apply only to the populations studied.

Evidence for use in Insomnia and Anxiety

Mirtazapine was evaluated in research exploring sleep disturbances. Evidence includes clinical trials and specific sleep laboratory studies (polysomnography) that measured objective parameters like time spent asleep. These studies often involved dosage parameters different from those used in MDD research. Evidence is limited in terms of duration for sleep outcomes, and long-term effects regarding tolerance are not fully established.

For Generalized Anxiety Disorder (GAD), the evidence base is smaller, derived from more modest RCTs that measured changes in anxiety severity ratings. Findings were mixed across the different study settings, and evidence quality varies for this indication.

Research Gaps and Uncertainty

Studies explored intermediate-term follow-up up to one year, but long-term effects are not fully established beyond this period. Research has also explored populations defined as older adults and those with treatment-resistant conditions. However, data for certain groups, including children or pregnant individuals, remain insufficient. The research landscape shows that certainty remains low in several areas, as findings reflect group patterns observed under specific study conditions, and research does not determine whether an individual will respond similarly.

Key Studies & References

  1. Mirtazapine for generalized anxiety disorder in adults: a systematic review and meta-analysis
  2. NICE Guideline NG222: Depression in adults: treatment and management

Frequently Asked Questions (FAQ)

Common questions about Bonec (FAQ)


Q: Are there any common supplements or vitamins that should be avoided while taking Bonec?

Official documents advise caution when taking non-prescription supplements and vitamins alongside Bonec. This is especially true for products that contain calcium, vitamin D, phosphorus, or magnesium, as these may increase the risk of side effects. To ensure proper absorption, administration of Bonec may require separation from other supplements, as noted in the administration guidelines.


Q: Do studies suggest Bonec starts working right away?

Studies and official information indicate that the time to effect depends on the medication's intended use. When Bonec is used as an antacid to neutralize stomach acid, the process typically begins immediately after ingestion, providing rapid symptomatic relief. However, when used for calcium supplementation, the full benefit to bone health is achieved over a much longer period of consistent use.


Q: Are there different strengths or forms (tablet, liquid) of Bonec available?

According to official product information, Bonec (Calcium Carbonate) is available in a variety of physical forms, including oral tablets, chewable tablets, and oral suspension (liquid). These forms, which contain varying strengths of elemental calcium, are authorized for both supplementation and antacid use.


Q: What does the FDA say about the long-term safety profile of Bonec?

Official safety documents address the potential for chronic effects, particularly when Bonec is taken at high doses over a long period. The profile includes warnings about the risk of hypercalcemia (high calcium levels) and potential effects on the kidneys. For antacid relief, the product information specifies a maximum duration of use, and administration is subject to specific constraints.


Q: What are the potential signs of an allergic reaction to Bonec?

Potential signs of an allergic reaction, as listed in official adverse event summaries, may include rash, hives, or itching. More serious signs may involve difficulty breathing or swallowing, as well as swelling of the mouth, face, lips, tongue, or throat.


Q: Does Bonec have a generic version available?

Yes, the active ingredient in Bonec, Calcium Carbonate, is a widely used compound. Because of this, generic versions are generally available on the market as both supplements and antacids.


Q: Does Bonec interact with common pain relievers like ibuprofen or aspirin?

Official drug interaction information notes that Bonec's ability to neutralize stomach acid may affect the absorption of certain other oral medications, including some anti-inflammatory drugs (NSAIDs), such as enteric-coated aspirin. For such combinations, administration constraints, such as specific timing separation, are typically provided in the product information.


Q: Is Bonec considered a controlled substance by the government?

No. Official regulatory listings classify the active ingredient in Bonec as a generally recognized as safe (GRAS) substance and a mineral supplement. It is not classified as a controlled substance by the U.S. government.


Q: Is Bonec known to cause skin rashes or sensitivity to the sun?

While the medication is generally well-tolerated, skin rash and hives are listed in official documents as potential signs of an allergic reaction or hypersensitivity to the medication's ingredients. It is not specifically noted for causing sun sensitivity.


Q: Does Bonec have known interactions with herbal teas or natural remedies?

Official documents caution that certain foods, particularly those high in phytic acid or oxalic acid, may interfere with Bonec's absorption. Additionally, co-administration with some specific supplements (such as Zinc or Fish Oil) has been noted as a potential interaction risk that should be monitored.


Q: How quickly do most patients notice a change after starting Bonec?

The change noticed depends entirely on the purpose for which Bonec is being taken. When used for antacid relief, the acid neutralization effect is typically felt right away. However, when used for mineral supplementation, the full systemic benefit is gradual and is built up over time with consistent use.


Q: What is the percentage of people in studies who experienced the most common side effect?

Official regulatory labels (such as the FDA label and the European SmPC) are required to contain precise information on the prevalence of side effects. These documents include specific percentages or frequency ranges (e.g., Rare, Uncommon) detailing how often particular side effects were observed in clinical trials.


Q: Is Bonec listed as having any major black box warnings?

The official product information for Bonec (Calcium Carbonate) does not list a major Black Box Warning. However, the label does include serious warnings about potential risks, such as high calcium levels and potential kidney damage associated with prolonged high-dose use.


Q: Are there any known interactions between Bonec and alcohol consumption?

Official drug labels do not list a specific drug-alcohol contraindication for Bonec. However, given that alcohol can irritate the digestive tract, there is a possibility that it could affect the underlying symptoms of stomach hyperacidity that Bonec is used to manage.


Q: Do any official documents describe Bonec as having a potential for dependency?

No. Based on its regulatory classification as a mineral supplement and antacid, official documentation does not indicate that Bonec (Calcium Carbonate) has any potential for dependency or abuse.


Q: Why is Bonec considered prescription-only?

Bonec, which contains Calcium Carbonate, is widely available over-the-counter (OTC) as both a supplement and an antacid product. However, certain higher-strength formulations or its use for specific medical conditions may be subject to prescription requirements.


Q: What is the official definition of the condition Bonec is intended to treat?

Bonec is officially described for two primary therapeutic purposes. First, it is intended to address Calcium deficiency in the body (supplementation). Second, it is intended to provide symptomatic relief from discomfort caused by stomach hyperacidity, such as heartburn and acid indigestion.


Q: Are there any known drug-disease interactions listed for Bonec?

Yes, official documents list several disease states that require caution or adjustment when taking Bonec. These interactions involve conditions related to kidney function, cardiac contraction or conduction, nutrient malabsorption, and certain conditions like sarcoidosis.

How should Bonec be stored and disposed of?

How to Store and Dispose of Bonec

Official regulatory guidelines for Bonec (Calcium Carbonate) specify precise requirements for storage, handling, and disposal to maintain the product’s quality and stability.

Required Storage Conditions

Bonec must be stored at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F). It is strictly required to protect the medication from light and moisture and avoid exposure to excessive heat. The product must not be frozen.

Packaging and Safety

The medication should be kept in the original container with the lid tightly closed. As a mandatory safety requirement, Bonec must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused Bonec must be properly discarded. It should not be disposed of in household wastewater or poured down a drain unless specifically authorized. Consult a pharmacist or local waste disposal service for the correct method to dispose of the medication in your area.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bonec found in:

A-Z Index: